ReleaseWire

In Silico Drug Discovery Market Statistics, Business Opportunities, Competitive Landscape and Industry Analysis Report by 2027

The growing demand for cost-effective medicines and the advent in genomics and proteomics applications will drive the demand for In Silico Drug Discovery.

Posted: Friday, March 12, 2021 at 2:48 PM CST

Vancouver, BC -- (SBWire) -- 03/12/2021 --The global In Silico Drug Discovery Market is forecasted to be worth USD 6.34 Billion by 2027, according to a current analysis by Emergen Research. The constant increase in the number of patients suffering from chronic diseases and pharmaceutical companies investing heavily in the development of various drugs are also influencing the market growth. The In silico drug discovery process help in the design and development of novel products.

Request for a sample report here@ https://www.emergenresearch.com/request-sample/373

It strives to offer accurate insights into the existing competitive landscape and the ever-growing competition in the industry. It also provides an idea about the strategic initiatives undertaken by the companies to fortify their footing in the market. The research report draws focus on the strengths and weaknesses of the key players of the market through a comprehensive SWOT analysis and Porter's Five Forces analysis to project the growth rate.

Key participants include Certara USA, Inc., Albany Molecular Research Inc., Chemical Computing Group ULC, Charles River, Dassault System (Biovia), Collaborative Drug Discovery Inc., Evotec A.G., ICAGEN, Inc., GVK Biosciences Private Limited, and Novo Informatics Pvt. Ltd., among others.

For the purpose of this report, Emergen Research has segmented into the global In Silico Drug Discovery Market on the workflow, product, type of large molecule, end-user, and region:

Workflow Outlook (Revenue, USD Billion; 2017-2027)
Discovery
Target Identification
Reverse Docking
Bioinformatics
Protein Structure Prediction
Target Validation
Lead Discovery
Pharmacophore
Library Design
Preclinical Tests
Clinical Trials

Product Outlook (Revenue, USD Billion; 2017-2027)
Consultancy as a Service
Software as a Service (Cloud)
Software

Type of Large Molecule Outlook (Revenue, USD Billion; 2017-2027)
Proteins
Antibodies
Nucleic Acids
Peptides
Vectors

End-User Outlook (Revenue, USD Billion; 2017-2027)
Contract Research Organizations
Pharmaceutical Industry
Academic and Research Institutes
Others

Regional Outlook (Revenue, USD Billion; 2017-2027)
North America
S.
Canada
Europe
Germany
UK
France
BENELUX
Rest of Europe
Asia Pacific
China
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
MEA
Saudi Arabia
UAE
Rest of MEA

Make an Inquiry of this report @ https://www.emergenresearch.com/purchase-enquiry/373

Objectives of the Global In Silico Drug Discovery Market Study:

An in-depth study of the evolving market sectors and the growth & penetration status of the global In Silico Drug Discovery market
COVID-19 Impact Analysis to highlight the major opportunities and challenges
Strategic recommendations to help readers formulate lucrative business strategies
Identification of the emerging players and their tactical approaches to expand market presence
An extensive study of the product portfolios of the major market players and their regional presence
A closer look at the strategic initiatives undertaken by the leading companies across this industry, including mergers & acquisitions, collaborations, partnerships, and joint ventures

Table of Content

Chapter 1. Methodology & Sources
    1.1. Market Definition
    1.2. Research Scope
    1.3. Methodology
    1.4. Research Sources
          1.4.1. Primary
          1.4.2. Secondary
          1.4.3. Paid Sources
    1.5. Market Estimation Technique
Chapter 2. Executive Summary
    2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. In Silico Drug Discovery Market Segmentation & Impact Analysis
    4.1. In Silico Drug Discovery Market Material Segmentation Analysis
    4.2. Industrial Outlook
          4.2.1. Market indicators analysis
          4.2.2. Market drivers analysis
                    4.2.2.1. Emphasis on Reduction in Medical Errors and Readmission Rates
                    4.2.2.2. Growth in the Biomarker Identification Market
          4.2.3. Market restraints analysis
                    4.2.3.1. Lack of High Complexity Testing Centers
    4.3. Technological Insights
    4.4. Regulatory Framework
    4.5. Porter's Five Forces Analysis
    4.6. Competitive Metric Space Analysis
    4.7. Price trend Analysis
    4.8. Covid-19 Impact Analysis

Chapter 5. In Silico Drug Discovery Market By Workflow Insights & Trends Revenue (USD Million)
    5.1. Workflow Dynamics & Market Share, 2019 & 2027
          5.1.1. Discovery
                    5.1.1.1. Target Identification
                                 5.1.1.1.1. Reverse Docking
                                 5.1.1.1.2. Bioinformatics
                                 5.1.1.1.3. Protein Structure Prediction
                    5.1.1.2. Target Validation
                    5.1.1.3. Lead Discovery
                                 5.1.1.3.1. Pharmacophore
                                 5.1.1.3.2. Library Design
          5.1.2. Pre-Clinical Tests
          5.1.3. Clinical Trials

Chapter 6. In Silico Drug Discovery Market By Product Insights & Trends Revenue (USD Million)
    6.1. Product Dynamics & Market Share, 2019 & 2027
          6.1.1. Consultancy as a Service
          6.1.2. Software as a Service (Cloud)
          6.1.3. Software

Chapter 7. In Silico Drug Discovery Market By Type of Large Molecule Insights & Trends Revenue (USD Million)
    7.1. Type of Large Molecule Dynamics & Market Share, 2019 & 2027
          7.1.1. Proteins
          7.1.2. Antibodies
          7.1.3. Nucleic Acids
          7.1.4. Peptides
          7.1.5. Vectors

Chapter 8. In Silico Drug Discovery Market By End User Insights & Trends Revenue (USD Million)
    8.1. End User Dynamics & Market Share, 2019 & 2027
          8.1.1. Contract Research Organizations
          8.1.2. Pharmaceutical Industry
          8.1.3. Academic and Research Institutes
          8.1.4. Others

CONTINUED..!!

Take a Look at our Related Reports:

Healthcare Business Intelligence Market Size

Ambulatory EHR Market Share

Healthcare CRM Market Growth

Fiber Cement Market Trends

Dairy Enzymes Market Demand

Cold Plasma Market Revenue

Industrial Lubricants Market Statistics

Cooling Fabrics Market Key Players Opportunities

Drug Screening Market Analysis

Mammography Workstations Market Development Strategy

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

Read Full Press Release: https://www.emergenresearch.com/press-release/global-in-silico-drug-discovery-market